Sunrest Lifescience IPO is a fixed price issue of Rs 10.85 crores. The issue is entirely a fresh issue of 12.91 lakh shares.
Sunrest Lifescience IPO opens for subscription on November 7, 2023 and closes on November 9, 2023. The allotment for the Sunrest Lifescience IPO is expected to be finalized on Wednesday, November 15, 2023. Sunrest Lifescience IPO will list on NSE SME with tentative listing date fixed as Monday, November 20, 2023.
Sunrest Lifescience IPO price is ₹84 per share. The minimum lot size for an application is 1600 Shares. The minimum amount of investment required by retail investors is ₹134,400. The minimum lot size investment for HNI is 2 lots (3,200 shares) amounting to ₹268,800.
Mark Corporate Advisors Private Limited is the book running lead manager of the Sunrest Lifescience IPO, while Skyline Financial Services Private Ltd is the registrar for the issue. The market maker for Sunrest Lifescience IPO is Svcm Securities.
Refer to Sunrest Lifescience IPO RHP for detailed information.
Sunrest Lifescience IPO Details
| IPO Date | November 7, 2023 to November 9, 2023 |
| Listing Date | [20 NOVEMBER 2023.] |
| Face Value | ₹10 per share |
| Price | ₹84 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 1,291,200 shares (aggregating up to ₹10.85 Cr) |
| Fresh Issue | 1,291,200 shares (aggregating up to ₹10.85 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 3,000,000 |
| Share holding post issue | 4,291,200 |
| Market Maker portion | 65,600 shares Svcm Securities |
Sunrest Lifescience IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| Retail Shares Offered | 50% of the Net issue |
| Other Shares Offered | 50% of the Net issue |
Sunrest Lifescience IPO Timeline (Tentative Schedule)
Sunrest Lifescience IPO opens on November 7, 2023, and closes on November 9, 2023.
| IPO Open Date | Tuesday, November 7, 2023 |
| IPO Close Date | Thursday, November 9, 2023 |
| Basis of Allotment | Wednesday, November 15, 2023 |
| Initiation of Refunds | Thursday, November 16, 2023 |
| Credit of Shares to Demat | Friday, November 17, 2023 |
| Listing Date | Monday, November 20, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on November 9, 2023 |
Sunrest Lifescience IPO Lot Size
Investors can bid for a minimum of 1600 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹134,400 |
| Retail (Max) | 1 | 1600 | ₹134,400 |
| HNI (Min) | 2 | 3,200 | ₹268,800 |
| Lot Size Calculator |
Sunrest Lifescience IPO Promoter Holding
The promoters of the company are Mr. Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakkar.
| Share Holding Pre Issue | 100% |
| Share Holding Post Issue | 69.91% |
About Sunrest Lifescience Limited
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.
The company’s product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience’s product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.
The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.
Sunrest Lifescience’s clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.
With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.
Sunrest Lifescience Limited Financial Information (Restated)
Sunrest Lifescience Limited’s revenue decreased by -8.32% and profit after tax (PAT) rose by 162.91% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 1,706.28 | 1,671.37 | 1,301.97 | 948.15 |
| Revenue | 563.58 | 2,467.05 | 2,690.99 | 1,694.91 |
| Profit After Tax | 75.08 | 204.31 | 77.71 | 16.55 |
| Net Worth | 386.60 | 311.52 | 107.20 | 29.49 |
| Reserves and Surplus | 86.60 | 11.52 | 106.20 | 28.49 |
| Total Borrowing | 347.32 | 214.32 | 323.83 | 231.55 |
| Amount in ₹ Lakhs |
Key Performance Indicator
| KPI | Values |
|---|---|
| P/E (x) | 12.33 |
| ROE | 53% |
| ROCE | 98% |
| Debt/Equity | 0.64 |
| EPS (Rs) | 6.81 |
| RoNW | 65.59% |
Check Sunrest Lifescience IPO Peer Comparison here.
Objects of the Issue (Sunrest Lifescience IPO Objectives)
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
1. Meeting Working Capital Requirements
2. General Corporate Purpose
3. Meeting Public Issue Expenses
Sunrest Lifescience Limited Contact Details
Sunrest Lifescience Limited
FF-41, Ajay Tenament-6,
Near Canal Near Ritanagar, Bus Stand Vastral Road,
Ahmedabad-382415
Phone: +91-079 – 29918245
Email: info@sunrestlifescience.com
Website: https://sunrestlifescience.com/
Sunrest Lifescience IPO Registrar
Skyline Financial Services Private Ltd
Phone: 02228511022
Email: Virenr@Skylinerta.Com
Website: https://www.skylinerta.com/ipo.php